Member Info for lukehere

ivyspivey-I don't know if this is relevant,but I cobbled it together from various sources over the weekend. Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings. Tyramine receptors belong to the Class A GPCR family. In mammalian systems, tyramine is a member of the trace amines, but in insects octopamine and tyramine are thought to be the main neurotransmitters. Dr.Essam Enan discovered,patented and assigned the technology to Tyratech. Embodiments of the present invention provide compositions for controlling a target pest including a pest control product and at least one active agent, wherein: the active agent can be capable of interacting with a receptor in the target pest; the pest control product can have a first activity against the target pest when applied without the active agent and the compositions can have a second activity against the target pest; and the second activity can be greater than the first activity. "Dr. Enan’s scientific research discoveries and breakthroughs have had significant impact on the industry. In 1996, Dr. Enan’s discovery of octopamine receptor as a target for some plant essential oils helped the business of a pesticide company producing natural insecticides in making and selling more effective products. In 2003, Dr. Enan’s screening platform was successfully created, established and used to identify and develop synergistic blends of plant essential oils with potent insecticidal activity. This groundbreaking work led directly to the creation of another pesticide company in April 2004, which went public on the London Stock Exchange (AIMS) in 2007. Dr. Enan is passionate about providing environmentally safer and all natural products that will drastically improve the quality of life for animals, plants, and humans, and has spent his career perfecting his science and inventions to achieve this goal. "

https://www.youtube.com/watch?v=6-zxyy_Rpk0&feature=youtu.be Maybe my last link was not direct. Share price looking very much as though it might go up with the MMs bidding 2.20 pence in size.

https://www.smartpakequine.com/pt/outsmart-fly-spray-14237 Based on this video, I believe that Tyratech might have a blockbuster on their hands. No wonder SmartPak are heavily promoting OutSmart .

Maybe we will see a holdings RNS,ivyspivey. Casting my mind back around 10 months when the TYRU share price went above 5 pence,there was buying on a huge scale,so it could be the same entity now exiting.Stranger things have happened. I bought a block this morning of that 1.7 million disposal yesterday. It is particularly difficult to see any downside with Tyratech at the moment. (Black swans please note and stay away)

Ivyspivey Tyratech has confirmed that it is considering its strategic options. If it transpires that they are intending to sell the "human health" division,this would explain why Jactel emphasised the fact that Vamousse was both cash generative and EBITDA positive.Normally -as with other items-we would get the normal,"in line with management expectations" patter. Some good buying of TYRU shares is taking place. It is a pity that we have a large and persistent seller,currently supplying the MMs at 2.25 pence. Without this "tap",I am of the opinion that the SP would be above 3 pence and rising.

I felt the same pwak. Bruno seemed intent on commenting on the two separate divisions=so much so that the potential for a (lucrative ?)spin off looks to be an option under consideration. Bruno indicated that the current thrust of R&D and other investment was being focused on animal heath. An interesting share to be in at the moment then,imo.

http://www.stocktube.com/video/6914/tyratech-boss-happy-to-be-able-to-grow-the-brand-amid-challenging-market-conditions-6914.html Our CEO telling us how it is. Positive business development across all divisions looks to be pretty well locked in for the year ahead. Surely the SP will start to reflect this before long. Good news could well be in the offing imo.

With "good feedback from several production facilities affiliated with the major poultry and swine producers in the US",and with "reports from partner MWI, the biggest distributor of animal health products in the US, showing that the products are performing well", Tyratech seem well positioned to make inroads into the multi US$ billion animal health market. I don't know what other posters thought,but imo the T/U read positively throughout with added diversification of the TYRU products stocked by retailers across the USA. In view of this and bearing in mind the reversal of the deceleration of the lice category in the US,it seemed odd that the T/U concluded that,"taking into account the market conditions and these new product placements and adoptions, the Board is currently more cautious about revenue expectations but still anticipates double digit revenue growth in 2017." Nevertheless,it does look as though 2017 should be much more interesting for Tyratech and its shareholders. I would be very encouraged if the share price were to edge up a touch in the shorter term for this would seem a fair initial reaction the trading update and the likelihood of some future interesting developments .

Kore wa toire o kudatte imasuga, ichido ni ukande shimau kamo shiremasen.

TYRU might not be about to set the world alight with soaring revenues through 2017,yet the trading update is positive throughout.. A change of strategic focus could well be beneficial as the BOD will be aware just how positive is the early feedback from PureScience users. With a fair wind holders might see the SP here move upwards-at last. imo.

jilso,I should have specified alternative reality,for herein lies the problem with reversing Fitbit into Fitbug. It is my understanding that two persons,one with a Fitbit and one with an Orb both jogging an exercising in identical fashion,obtain very divergent device feedback .

I believe that Lord Coe would be a useful addition to the Board. As regards technology,would it not be advantageous if the FITB Orb might upgraded to incorporate some virtual reality features for therein lies the future.

Fundraising occurred @ 40. Warrants exercisable @ 40 Share options triggered on SP reaching 40 Loan notes conversion @ 40 Investors fortified @ 40 ?

In a new report that surveyed international entertainment industry professionals,ZOO ranks 8th in the survey for its technological innovations in localisation and digital distribution. ZOO appears alongside major global brands and household names including Amazon, Sky, Google, BBC and Apple and is the only company involved in localisation amongst the 25 names recognised. Below ZOO are the likes of IBM and Microsoft.

Midas is singing from my hymn sheet. . We are now seeing reduced volatility whilst the SP edges down. One day the "concert party" might show its hand and all hell might then break loose. In the meantime I will wait for the share price to move below .015 before re investing. FITB remains very entertaining show.

The days of erratic share price movements for FITB shares have passed. In my opinion we might now see the share price drift very slowly down towards 0.12. If so,boredom will also set in and we will revert to a handful of posts each day,at best Not for excitement seekers for some time yet,although somewhere out there lies further action of a boom or bust nature.

Well if the trading update issued this morning is anything to go by,any breakout should be significantly upward. With EBITDA projected to be a MINIMUM of US$ 1.8 million(£1.43 million) against a £3million M/C surely something needs to give. The year commencing April 1st 2017 should be stronger still. Let the upward re rating continue.

The new placing should surely trigger a holding RNS or two. If we learn who the holders of these new shares are,it might provide a clue as to where FITB is going !

This is a repeat of the trading scenario in the months preceding Jan 18th,when again one could continually buy at bid price or below,with the SP marked downwards retrospectively . Buyers think they are securing a bargain whilst sellers are frustrated for the MMs are disinclined to take stock within the spread.This coincided with the evaporation of any volatility in the SP. Maybe not much excitement lying ahead then for FITB holders in the short term. imo.

KNIGELK is accurate regarding the intra day high.It was a fleeting moment but it was there,as was I,but regretfully without a holding having sold at just 1pence .